SBI Healthcare Opportunities Fund vs Tata India Pharma & Healthcare Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3522 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 32% | 26.49% |
Expense Ratio | 1.94 | 2.14 |
Manager | Pradeep Kesavan | Meeta Shetty |
ISIN Code | INF200K01446 | INF277K016A9 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 6.96% | 7.32% |
6 Month | -2.35% | -8.06% |
1 Year | 19.83% | 14.27% |
3 Year | 22.87% | 18.55% |
5 Year | 29.3% | 26.23% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | -1.91% | -5.45% |
1 Year | 10.16% | -0.3% |
3 Year | 28.36% | 23.71% |
5 Year | 22.98% | 19.72% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 15.04% | 7.82% |
3 Year | 17.32% | 17.79% |
5 Year | 12.58% | 14.55% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 14.597% | 16.538% |
Sharp | 0.987% | 0.681% |
Beta | 0.85% | 0.969% |
Alpha | 4.505% | 0.018% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Pradeep Kesavan | Meeta Shetty |
Total AUM | ₹434274 Cr | ₹17847 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 6.48 | 5.06 |
Small Cap | 37.63 | 27.82 |
Mid Cap | 28.02 | 31.87 |
Large Cap | 27.87 | 35.26 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.8 | 4.34 |
Basic Materials | 6.85 | 2.22 |
Healthcare | 91.34 | 93.44 |
Top Comparisons
ITI ELSS Tax Saver Fund Regular - Growth
3Y Returns18.18%
Edelweiss ELSS Tax saver Fund - Regular Plan - Growth Option
3Y Returns12.87%
Nippon India Large Cap Fund- Growth Plan Bonus Option
3Y Returns18.29%
Sundaram Large Cap Fund Regular Plan - Growth
3Y Returns10.98%
Aditya Birla Sun Life Flexi Cap Fund - Growth - Regular Plan
3Y Returns13.3%
Axis Flexi Cap Fund - Regular Plan - Growth
3Y Returns9.62%
Kotak Equity Opportunities Fund - Growth
3Y Returns16.59%
DSP Equity Opportunities Fund-Regular Plan - Growth
3Y Returns19.33%